A detailed history of Bank Of America Corp transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 558,987 shares of PCRX stock, worth $9.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
558,987
Previous 599,399 6.74%
Holding current value
$9.88 Million
Previous $17.5 Million 8.69%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.5 - $31.51 $1.03 Million - $1.27 Million
-40,412 Reduced 6.74%
558,987 $16 Million
Q1 2024

May 15, 2024

BUY
$27.7 - $35.48 $3.99 Million - $5.12 Million
144,184 Added 31.67%
599,399 $17.5 Million
Q4 2023

Feb 14, 2024

BUY
$26.32 - $34.31 $7.13 Million - $9.29 Million
270,814 Added 146.86%
455,215 $15.4 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $47.5 $1.5 Million - $1.98 Million
-41,641 Reduced 18.42%
184,401 $7.39 Million
Q1 2023

May 12, 2023

BUY
$35.53 - $43.38 $1.7 Million - $2.08 Million
47,975 Added 26.94%
226,042 $9.22 Million
Q4 2022

Feb 10, 2023

SELL
$38.19 - $57.45 $615,088 - $925,289
-16,106 Reduced 8.29%
178,067 $6.88 Million
Q3 2022

Nov 14, 2022

SELL
$51.24 - $58.89 $1.42 Million - $1.63 Million
-27,647 Reduced 12.46%
194,173 $10.3 Million
Q2 2022

Aug 12, 2022

BUY
$51.49 - $81.64 $1.43 Million - $2.27 Million
27,769 Added 14.31%
221,820 $12.9 Million
Q1 2022

May 16, 2022

BUY
$60.03 - $76.49 $213,526 - $272,074
3,557 Added 1.87%
194,051 $14.8 Million
Q4 2021

Feb 08, 2022

SELL
$47.97 - $62.21 $478,980 - $621,166
-9,985 Reduced 4.98%
190,494 $11.5 Million
Q3 2021

Nov 15, 2021

BUY
$54.64 - $61.3 $1.01 Million - $1.13 Million
18,461 Added 10.14%
200,479 $11.2 Million
Q2 2021

Sep 13, 2021

BUY
$59.18 - $69.99 $10.8 Million - $12.7 Million
182,018 New
182,018 $11 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $810M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.